ZVRA
Zevra Therapeutics Inc.
Latest News for ZVRA
In a report released on April 2, Kambiz Yazdi from BTIG maintained a Buy rating on Zevra Therapeutics, with a price target of $23.00. According to ......
In a report released on April 2, Kambiz Yazdi from BTIG maintained a Buy rating on Zevra Therapeutics, with a price target of $23.00. According to ......
Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new B......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Zevra Therapeutics (ZVRA – Research Report), Verrica Pharmaceutic......
In a report released today, from Roth MKM maintained a Buy rating on Zevra Therapeutics, with a price target of $21.00. In addition to Roth MKM, Ze......
Zevra Therapeutics ( ($ZVRA) ) has shared an announcement. On March 4, 2026, Zevra appointed industry veteran Justin Renz as Chief Financial Office......
News data is sourced from MarketXLS API and updated regularly.
Showing 6 of 6 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ZVRA | $9.63 | -0.5% | 391.93K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |